| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/25/2013 | CN103462946A New applications of protocatechuic acid in preparing medicaments |
| 12/25/2013 | CN103462933A Fasligand antibody coupled and polyethylene glycol (PEG) modified lipid nanometer drug delivery system and application thereof |
| 12/25/2013 | CN103462921A Drug sustained-release preparation and preparation method thereof |
| 12/25/2013 | CN103462913A Galenic formulations of organic compounds |
| 12/25/2013 | CN103462911A Preparation technique of freeze-dried powder injection |
| 12/25/2013 | CN103462893A Estradiol transdermal spray and its preparation method |
| 12/25/2013 | CN103462888A Substituted beta-cyclodextrin included vinpocetine injection and preparation method thereof |
| 12/25/2013 | CN103462002A 维生素c泡腾片及其制备方法 Effervescent vitamin c and its preparation method |
| 12/25/2013 | CN103461788A Flour compound suitable for hypertensive disease patients |
| 12/25/2013 | CN103142529B Indapamide sustained-release drug composite and preparation method thereof |
| 12/25/2013 | CN102973520B Diethylamide ethylenediamine compound-containing drug composition |
| 12/25/2013 | CN102824644B High-stability sustained-release tablet prepared by using hydroxy propyl cellulose |
| 12/25/2013 | CN102824417B New method for treating helicobacter pylori related diseases |
| 12/25/2013 | CN102755540B Drug for health care recuperation of hypertension patients |
| 12/25/2013 | CN102727486B Application of Inula lineariifolia lactone A in preparation of medicine for treating myocarditis |
| 12/25/2013 | CN102698092B Traditional Chinese medicine composition for treating liver-Yang hyperactivity-type hypertension |
| 12/25/2013 | CN102698039B Pine needle tea beverage |
| 12/25/2013 | CN102671128B Drug for treating arteriosclerosis |
| 12/25/2013 | CN102641480B Traditional Chinese medicine composite used for treating microcirculation disturbance and preparation method thereof |
| 12/25/2013 | CN102641415B Traditional Chinese medicine composition for treating hemorrhoids |
| 12/25/2013 | CN102614484B Bathing traditional Chinese medicine for adjuvant therapy of cerebral thrombosis and hypertension and method for preparing same |
| 12/25/2013 | CN102579396B Calcium dobesilate capsule composition |
| 12/25/2013 | CN102526174B Isosorbide mononitrate and preparation technology thereof |
| 12/25/2013 | CN102512391B Azelnidipine quick-releasing drug preparation and preparation method |
| 12/25/2013 | CN102504006B Steroid saponin compound in siberian fritillary bulb |
| 12/25/2013 | CN102475830B Medicinal composition for treating coronary disease and angina pectoris, preparation method thereof and preparation thereof |
| 12/25/2013 | CN102311502B Fusion protein used for inhibiting regeneration or growth of blood vessel and medical treatment application thereof |
| 12/25/2013 | CN102174046B Tetomilast polymorphs |
| 12/25/2013 | CN102164920B Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 12/25/2013 | CN102149376B Long-term treatment of symptomatic heart failure |
| 12/25/2013 | CN102100739B Traditional Chinese medicine composition containing salvianic acid A and pseudoginseng root saponin R1 and application thereof |
| 12/25/2013 | CN102085208B Pharmaceutical composition for treating coronary heart disease and angina |
| 12/25/2013 | CN102058872B Medicinal composition containing Lysinopril and amlodipine besilate and preparation method thereof |
| 12/25/2013 | CN102020602B Crystal form of lercanidipine hydrochloride and preparation method thereof and crystal form-containing medicinal composition |
| 12/25/2013 | CN101787073B Methods and compositions for treatment of gastrointestinal disorders |
| 12/25/2013 | CN101747170B Conjugated type coenzyme Q analogue, preparation method and application thereof |
| 12/25/2013 | CN101573048B Use of nutritional compositions for preventing disorders |
| 12/25/2013 | CA2820388A1 A preparation used for anti-tachyarrhythmia and its preparation method |
| 12/24/2013 | US8613948 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 12/24/2013 | US8613945 Stable pharmaceutical composition and methods of using same |
| 12/24/2013 | US8613920 Treatment of amyloidogenic diseases |
| 12/24/2013 | CA2613059C Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
| 12/24/2013 | CA2605510C Inhibitors of microsomal triglyceride transfer protein and apo-b secretion |
| 12/24/2013 | CA2587188C Pharmaceutical preparation for the treatment of friedreich's ataxia |
| 12/24/2013 | CA2520372C Stq-peptides |
| 12/24/2013 | CA2457461C Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 12/24/2013 | CA2393816C Process for obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ros scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 12/19/2013 | WO2013188882A1 Macromolecules for treating atherosclerosis |
| 12/19/2013 | WO2013188787A1 INHIBITORS OF MICRORNAs THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF |
| 12/19/2013 | WO2013188258A1 Use of hmb to improve health outcomes for hospitalized patients |
| 12/19/2013 | WO2013187467A1 Heteroaromatic methyl cyclic amine derivative |
| 12/19/2013 | WO2013187466A1 Branched chain alkyl heteroaromatic ring derivative |
| 12/19/2013 | WO2013187462A1 Piperidinylpyrazolopyridine derivative |
| 12/19/2013 | WO2013187391A1 COMPOSITION COMPRISING SESAMIN COMPOUND, γ-ORIZANOL AND RICE GERM OIL |
| 12/19/2013 | WO2013187381A1 Method for producing ppar activator, and ppar activator |
| 12/19/2013 | WO2013187075A1 Prophylactic and/or therapeutic agent for mild cognitive impairment |
| 12/19/2013 | WO2013186680A1 Feijoa fruit extract |
| 12/19/2013 | WO2013185214A1 Pla2g7/lp-pla2 as biomarker and therapeutic target in the prevention and treatment of calcific aortic valve disease |
| 12/19/2013 | US20130338071 GLP-1 Agonist and Cardiovascular Complications |
| 12/19/2013 | US20130337041 Charged phospholipid compositions and methods for their use |
| 12/19/2013 | US20130336985 Medicament and a method for regulation of the vascular tone |
| 12/19/2013 | CA2876382A1 Piperidinylpyrazolopyridine derivative |
| 12/19/2013 | CA2876371A1 Prophylactic and/or therapeutic agent for mild cognitive impairment |
| 12/19/2013 | CA2876253A1 Heteroaromatic methyl cyclic amine derivative |
| 12/19/2013 | CA2876249A1 Branched chain alkyl heteroaromatic ring derivative |
| 12/19/2013 | CA2875504A1 Feijoa fruit extract |
| 12/18/2013 | EP2674417A2 Biaryl PDE4 inhibitors for treating inflammation |
| 12/18/2013 | EP2674157A1 Therapeutic agent for diastolic congestive heart failure |
| 12/18/2013 | EP2674155A1 Association of resveratrol and carboxymethylglucan |
| 12/18/2013 | EP2673289A1 Viral vectors with modified transduction profiles and methods of making and using the same |
| 12/18/2013 | EP2672975A1 Methods for treating pulmonary hypertension |
| 12/18/2013 | EP2672965A2 Treatment and prevention of cardiovascular disease and thrombosis |
| 12/18/2013 | EP2672927A2 Atrial appendage occlusion and arrhythmia treatment |
| 12/18/2013 | EP2523961B1 2,5,7-substituted oxazolopyrimidine derivatives |
| 12/18/2013 | EP2521726B1 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as camkii kinases inhibitors for the treatment of cardiovascular diseases |
| 12/18/2013 | EP2426109B1 Novel kinase inhibitors |
| 12/18/2013 | EP2203061B1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 12/18/2013 | EP2059519B1 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 12/18/2013 | EP1999111B1 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists |
| 12/18/2013 | EP1982710B1 Composition for prevention of recurrence of stroke |
| 12/18/2013 | EP1948183B1 Compositions for the treatment and prevention of heart disease and methods of using same |
| 12/18/2013 | EP1814527B1 Bilayer tablet comprising telmisartan and amlodipine |
| 12/18/2013 | EP1656952B1 Polyalkylene glycol conjugates of interferon beta-1A and uses thereof |
| 12/18/2013 | EP1439187B1 O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 12/18/2013 | CN103459590A Pluripotent stem cell capable of being isolated from fat tissue or umbilical cord of biological body |
| 12/18/2013 | CN103459383A Pyrazole compounds |
| 12/18/2013 | CN103459381A 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof |
| 12/18/2013 | CN103459380A Novel phenylpyridine derivative and drug containing same |
| 12/18/2013 | CN103459369A 胍化合物 Guanidine compound |
| 12/18/2013 | CN103459362A A complex of garcinol, cyclodextrin and method thereof |
| 12/18/2013 | CN103458903A Radiopaque embolic particles |
| 12/18/2013 | CN103451246A Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
| 12/18/2013 | CN103451072A Method for producing Puer tea wine |
| 12/18/2013 | CN103450345A Vip片段和应用方法 Vip fragments and application methods |
| 12/18/2013 | CN103450325A Tanshinone II A sulfonate, preparation method, and applications thereof |
| 12/18/2013 | CN103450214A Glucopyranesyl derivative, preparation method thereof and application thereof in medicines |
| 12/18/2013 | CN103450171A Novel immune adjustment compound, application thereof and medicine combination comprising same |
| 12/18/2013 | CN103450163A Indazole compounds, preparation method, and pharmaceutical applications thereof |
| 12/18/2013 | CN103450134A Preparation of coumarin derivative and application of coumarin derivative to control of serious cerebral disease |
| 12/18/2013 | CN103450087A Preparation method of paeonol and ozagrel conjugate |